These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1299431)

  • 21. Licensure of "new generation" conjugated Haemophilus influenzae type b vaccines.
    Hansman D
    Med J Aust; 1992 Sep; 157(6):430-1. PubMed ID: 1448014
    [No Abstract]   [Full Text] [Related]  

  • 22. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.
    Anderson PW; Stein EC; Insel RA
    Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statement on Haemophilus influenzae type b polysaccharide vaccine.
    CMAJ; 1986 Jun; 134(12):1375-6. PubMed ID: 3486707
    [No Abstract]   [Full Text] [Related]  

  • 25. The introduction of Haemophilus influenzae B (Hib) vaccine.
    Murphy JF
    Ir Med J; 1992 Dec; 85(4):123. PubMed ID: 1473940
    [No Abstract]   [Full Text] [Related]  

  • 26. Hib vaccine is available and soon to be required.
    Kelley MF
    Tex Med; 1991 Jan; 87(1):8. PubMed ID: 1998163
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil.
    Ribeiro GS; Reis JN; Cordeiro SM; Lima JB; Gouveia EL; Petersen M; Salgado K; Silva HR; Zanella RC; Almeida SC; Brandileone MC; Reis MG; Ko AI
    J Infect Dis; 2003 Jan; 187(1):109-16. PubMed ID: 12508153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leads from the MMWR. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    JAMA; 1985 May; 253(18):2630, 2636-7. PubMed ID: 3872947
    [No Abstract]   [Full Text] [Related]  

  • 29. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemophilus influenzae vaccine: maximizing uptake.
    Booy R; Marriage SC; Davies H
    Br J Gen Pract; 1995 Oct; 45(399):563. PubMed ID: 7492430
    [No Abstract]   [Full Text] [Related]  

  • 31. [Haemophilus influenzae meningitis in Austria: 1990-1992 incidence].
    Vutuc C; Kunze M
    Wien Klin Wochenschr; 1995; 107(8):256-7. PubMed ID: 7762246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1992 Apr; 146(8):1363-72. PubMed ID: 1555165
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data.
    Peltola H; Salo E; Saxén H
    BMJ; 2005 Jan; 330(7481):18-9. PubMed ID: 15564230
    [No Abstract]   [Full Text] [Related]  

  • 34. Haemophilus influenzae type b vaccine.
    Gilsdorf JR
    Indian J Pediatr; 1988; 55(2):218-24. PubMed ID: 3042621
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Costs and benefits of vaccination against Haemophilus influenzae type b].
    Martens LL; ten Velden GH; Bol P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(1):16-20. PubMed ID: 1899290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hib vaccination: recent paper from Finland suggests that a prolonged three dose schedule offers effective protection against disease.
    European Union Invasive Bacterial Infection Surveillance scheme
    Euro Surveill; 2005 Jan; 10(1):E050113.1. PubMed ID: 16556943
    [No Abstract]   [Full Text] [Related]  

  • 38. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA workshop on Haemophilus b polysaccharide vaccine--a preliminary report.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Aug; 36(32):529-31. PubMed ID: 3112543
    [No Abstract]   [Full Text] [Related]  

  • 40. H. influenzae vaccine for infants.
    Med Lett Drugs Ther; 1991 Jan; 33(836):5-7. PubMed ID: 1986208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.